These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26085578)

  • 1. Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy.
    Sawyer SL; Cheuk-Him Ng A; Innes AM; Wagner JD; Dyment DA; Tetreault M; ; Majewski J; Boycott KM; Screaton RA; Nicholson G
    Hum Mol Genet; 2015 Sep; 24(18):5109-14. PubMed ID: 26085578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.
    Capel E; Vatier C; Cervera P; Stojkovic T; Disse E; Cottereau AS; Auclair M; Verpont MC; Mosbah H; Gourdy P; Barraud S; Miquel A; Züchner S; Bonnefond A; Froguel P; Christin-Maitre S; Delemer B; Fève B; Laville M; Robert J; Tenenbaum F; Lascols O; Vigouroux C; Jéru I
    J Clin Lipidol; 2018; 12(6):1420-1435. PubMed ID: 30158064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene.
    Ababneh NA; Ali D; Barham R; Al-Kurdi B; Sharar N; Al Hadidi S; Qanno' O; Ryalat AT; Salah B; Awidi A
    Stem Cell Res; 2020 Oct; 48():101967. PubMed ID: 32916636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
    Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
    Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy.
    Zolotov S; Xing C; Mahamid R; Shalata A; Sheikh-Ahmad M; Garg A
    Am J Med Genet A; 2017 Jan; 173(1):190-194. PubMed ID: 27862896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing reveals mutations in MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease.
    Kostera-Pruszczyk A; Kosinska J; Pollak A; Stawinski P; Walczak A; Wasilewska K; Potulska-Chromik A; Szczudlik P; Kaminska A; Ploski R
    J Peripher Nerv Syst; 2014 Sep; 19(3):242-5. PubMed ID: 25403865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype.
    Iapadre G; Morana G; Vari MS; Pinto F; Lanteri P; Tessa A; Santorelli FM; Striano P; Verrotti A
    Eur J Paediatr Neurol; 2018 May; 22(3):563-567. PubMed ID: 29361379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features.
    Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E
    JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
    Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
    Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA mutations in multiple symmetric lipomatosis.
    Klopstock T; Naumann M; Seibel P; Shalke B; Reiners K; Reichmann H
    Mol Cell Biochem; 1997 Sep; 174(1-2):271-5. PubMed ID: 9309699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational mechanisms in MFN2-related neuropathy: compound heterozygosity for recessive and semidominant mutations.
    Piscosquito G; Saveri P; Magri S; Ciano C; Di Bella D; Milani M; Taroni F; Pareyson D
    J Peripher Nerv Syst; 2015 Dec; 20(4):380-6. PubMed ID: 26306937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcyphosine-like (CAPSL) is regulated in Multiple Symmetric Lipomatosis and is involved in Adipogenesis.
    Lindner A; Marbach F; Tschernitz S; Ortner C; Berneburg M; Felthaus O; Prantl L; Kye MJ; Rappl G; Altmüller J; Thiele H; Schreml S; Schreml J
    Sci Rep; 2019 Jun; 9(1):8444. PubMed ID: 31186450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model.
    Strickland AV; Rebelo AP; Zhang F; Price J; Bolon B; Silva JP; Wen R; Züchner S
    J Peripher Nerv Syst; 2014 Jun; 19(2):152-64. PubMed ID: 24862862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mitofusin 2 splice-site mutation causes Charcot-Marie-Tooth disease type 2 with prominent sensory dysfunction.
    Martikainen MH; Kytövuori L; Majamaa K
    Neuromuscul Disord; 2014 Apr; 24(4):360-4. PubMed ID: 24530046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum and frequencies of mutations in the MFN2 gene and its phenotypical expression in Czech hereditary motor and sensory neuropathy type II patients.
    Brožková DŠ; Posádka J; Laššuthová P; Mazanec R; Haberlová J; Sišková D; Sakmaryová I; Neupauerová J; Seeman P
    Mol Med Rep; 2013 Dec; 8(6):1779-84. PubMed ID: 24126688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel p.Val244Leu mutation in MFN2 leads to Charcot-Marie-Tooth disease type 2.
    Yang Y; Li L
    Ital J Pediatr; 2016 Mar; 42():28. PubMed ID: 26956144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset Charcot-Marie-Tooth neuropathy type 2A and severe developmental delay: expanding the clinical phenotype of MFN2-related neuropathy.
    Tufano M; Cappuccio G; Terrone G; Manganelli F; Pisciotta C; Geroldi A; Capponi S; Del Giudice E
    J Peripher Nerv Syst; 2015 Dec; 20(4):415-8. PubMed ID: 26307494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel homozygous mutations in Pakistani families with Charcot-Marie-Tooth disease.
    Kanwal S; Choi YJ; Lim SO; Choi HJ; Park JH; Nuzhat R; Khan A; Perveen S; Choi BO; Chung KW
    BMC Med Genomics; 2021 Jun; 14(1):174. PubMed ID: 34193129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.